Nuclear Medicine: Page 343

MDS Nordion opens European TheraSphere centers

By AuntMinnie.com staff writers

Radioisotope developer MDS Nordion of Kanata, Ontario, said it has established four centers of excellence in Europe for its liver cancer treatment product, TheraSphere.

February 7, 2007

DraxImage to bring generic sestamibi to market

By AuntMinnie.com staff writers

Canadian radiopharmaceutical firm DraxImage has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration for its generic kit for the preparation of technetium-99m (Tc-99m) sestamibi.

February 1, 2007

Study: PET accurate for newborns' pancreatic defects

By AuntMinnie.com staff writers

Positron emission tomography (PET) is extremely accurate in diagnosing a type of congenital hyperinsulinism (HI), a rare but severe imbalance of insulin levels in newborns.

January 29, 2007

RAE Systems introduces two new dosimeters

By AuntMinnie.com staff writers

RAE Systems of San Jose, CA, has introduced the DoseRAE and DoseRAE-P Geiger-Mueller tube-based, electronic gamma radiation dosimeters.

January 29, 2007

Advanced Medical Isotopes licenses actinium patent

By AuntMinnie.com staff writers

Medical isotope developer Advanced Medical Isotopes of Kennewick, WA, reported that it has licensed a U.S. patent for preparing actinium-225.

January 25, 2007

EBRT/brachytherapy prostate cancer combo shows long-term effectiveness

By Jonathan S. Batchelor

The pairing of external-beam radiation therapy (EBRT) followed by brachytherapy has shown strong results in long-term relapse-free survival rates in prostate cancer patients, according to researchers of a new study. They found that low- and intermediate-risk patients experienced high disease-free survival rates with this treatment.

January 24, 2007

Study: PET posts double-digit gains in Western Europe

By AuntMinnie.com staff writers

A study by healthcare consultants Medical Options of London estimated that 491,000 patient studies will be performed using PET in Western Europe in 2006.

January 21, 2007

Bayer Schering to develop PET brain imaging agents

By AuntMinnie.com staff writers

Berlin-based Bayer Schering Pharma (formerly Schering) has signed a license and option agreement with two Japanese companies and the National Institute of Radiological Sciences (NIRS) in Japan to develop imaging compounds for detecting neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.

January 18, 2007

IBA expands production capacity

By AuntMinnie.com staff writers

Nuclear medicine products firm Ion Beam Applications (IBA) has launched an expansion program to meet the demand for its proton therapy systems.

January 18, 2007

New tracer shows promise for PET/CT prostate imaging

By Jonathan S. Batchelor

One in six men in the U.S. will get prostate cancer during his lifetime, according to recent data. Unfortunately, conventional imaging techniques are limited for detecting, staging, and restaging this carcinoma. But a study by scientists at Emory University in Atlanta and researchers in Japan finds that a new radiotracer shows promse in evaluating and staging prostate cancer.

January 17, 2007

2007 01 17 17 19 14 706

IsoRay adds cesium-131 sites

By AuntMinnie.com staff writers

Medical isotope developer IsoRay Medical has increased the number of sites either producing or getting ready to produce cesium-131.

January 16, 2007

Fuji renames Daiichi subsidiary

By AuntMinnie.com staff writers

Japanese film and technology company Fujifilm has applied its corporate branding to its recently acquired Daiichi Radioisotope Laboratories (DRL) subsidiary, with the division to be known as Fujifilm RI Pharma, effective April 1.

January 16, 2007

Page 343 of 439